AR113492A2 - Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla - Google Patents

Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla

Info

Publication number
AR113492A2
AR113492A2 ARP180103625A ARP180103625A AR113492A2 AR 113492 A2 AR113492 A2 AR 113492A2 AR P180103625 A ARP180103625 A AR P180103625A AR P180103625 A ARP180103625 A AR P180103625A AR 113492 A2 AR113492 A2 AR 113492A2
Authority
AR
Argentina
Prior art keywords
methods
free
produce
animal proteins
substantially animal
Prior art date
Application number
ARP180103625A
Other languages
English (en)
Original Assignee
Baxalta GmbH
Baxalta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40524590&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR113492(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxalta GmbH, Baxalta Inc filed Critical Baxalta GmbH
Publication of AR113492A2 publication Critical patent/AR113492A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Furina recombinante (rFurina) y métodos para producir la rFurina. Más específicamente, rFurina libre de proteínas sustancialmente animal y métodos para producir la rFurina libre de proteínas sustancialmente animales.
ARP180103625A 2007-12-31 2018-12-12 Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla AR113492A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1815207P 2007-12-31 2007-12-31

Publications (1)

Publication Number Publication Date
AR113492A2 true AR113492A2 (es) 2020-05-06

Family

ID=40524590

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP080105645 AR069892A1 (es) 2007-12-31 2008-12-19 Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion.
ARP180103625A AR113492A2 (es) 2007-12-31 2018-12-12 Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP080105645 AR069892A1 (es) 2007-12-31 2008-12-19 Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion.

Country Status (18)

Country Link
US (2) US20090181423A1 (es)
EP (2) EP2240578B1 (es)
JP (2) JP5806465B2 (es)
KR (1) KR101618144B1 (es)
CN (2) CN110066782B (es)
AR (2) AR069892A1 (es)
AU (1) AU2008346817B2 (es)
BR (1) BRPI0821467B8 (es)
CA (1) CA2710260C (es)
DK (1) DK2240578T3 (es)
ES (2) ES2735173T3 (es)
HU (1) HUE043863T2 (es)
MX (1) MX2010007344A (es)
NZ (1) NZ586411A (es)
PL (2) PL2240578T3 (es)
PT (1) PT2240578T (es)
SG (2) SG10201805749QA (es)
WO (1) WO2009088713A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2157177E (pt) * 2007-05-22 2013-04-18 Baxter Int Processo de purificação preparativo para a furina humana
MX2010007344A (es) 2007-12-31 2010-11-09 Baxter Int Furina recombinante substancialmente libre de proteina animal y metodos para la produccion de la misma.
US8241623B1 (en) 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
PT3626736T (pt) 2010-07-08 2025-08-11 Takeda Pharmaceuticals Co Método de produção de fvw recombinante de elevado peso molecular na cultura celular
US20140051832A1 (en) * 2011-03-11 2014-02-20 Universidade De São Paulo - Usp Method for the production of recombinant human factor viii
AU2012261813B2 (en) 2011-06-02 2017-04-20 Takeda Pharmaceutical Company Limited Formulations of recombinant furin
TWI666319B (zh) * 2014-08-12 2019-07-21 美商巴克斯歐塔公司 在分泌ｆｕｒｉｎ之哺乳動物表現系統中生產經完全加工且具功能性之因子Ｘ
CA3225136A1 (en) 2014-12-22 2016-06-30 Genzyme Corporation Methods of culturing a mammalian cell
JP7253505B2 (ja) 2017-06-23 2023-04-06 武田薬品工業株式会社 第ｖｉｉｉ因子亜種の精製
PH12023551306A1 (en) * 2020-11-13 2023-11-20 Icosavax Inc Protein-based nanoparticle vaccine for metapneumovirus

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1815207A (en) 1929-01-18 1931-07-21 John H Moffat Vehicle parking and locking device
NL9000917A (nl) 1989-10-25 1991-05-16 Holland Biotechnology Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten.
EP0785273A1 (en) * 1990-11-26 1997-07-23 Genetics Institute, Inc. Paired basic amino acid converting enzyme and DNA sequence encoding it
US5604201A (en) * 1993-01-08 1997-02-18 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization Methods and reagents for inhibiting furin endoprotease
AT404838B (de) * 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
JP4543402B2 (ja) 1996-10-10 2010-09-15 ライフ テクノロジーズ コーポレーション 植物由来栄養素を含む動物細胞培養培地
AT407750B (de) 1999-02-19 2001-05-25 Immuno Ag Verfahren zur herstellung einer vwf-präparation
US6596526B1 (en) * 2000-06-09 2003-07-22 Baxter Aktiengesellschaft Furin polypeptides with improved characteristics
SE0103084D0 (sv) * 2001-09-14 2001-09-14 Amersham Pharm Biotech Ab Generation of ion exchange media
US20030091976A1 (en) 2001-11-14 2003-05-15 Ciphergen Biosystems, Inc. Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
CA2491992A1 (en) * 2002-07-09 2004-01-15 Baxter International, Inc. Animal protein free media for cultivation of cells
CA2552639C (en) * 2004-02-27 2012-05-01 Ge Healthcare Bio-Sciences Ab A process for the purification of antibodies
SI2522717T1 (sl) * 2006-01-04 2014-05-30 Baxter International Inc. Mediji celične kulture brez oligopeptidov
PT2157177E (pt) 2007-05-22 2013-04-18 Baxter Int Processo de purificação preparativo para a furina humana
MX2010007344A (es) 2007-12-31 2010-11-09 Baxter Int Furina recombinante substancialmente libre de proteina animal y metodos para la produccion de la misma.
WO2013070520A2 (en) 2011-11-03 2013-05-16 Barson Composites Corporation Corrosion-resistant diffusion coatings

Also Published As

Publication number Publication date
SG192471A1 (en) 2013-08-30
AU2008346817A1 (en) 2009-07-16
HUE043863T2 (hu) 2019-09-30
ES2897561T3 (es) 2022-03-01
EP3521422B1 (en) 2021-10-06
KR101618144B1 (ko) 2016-05-17
JP2015154790A (ja) 2015-08-27
ES2735173T3 (es) 2019-12-16
NZ586411A (en) 2012-06-29
SG10201805749QA (en) 2018-08-30
WO2009088713A1 (en) 2009-07-16
PL3521422T3 (pl) 2021-12-20
CN110066782B (zh) 2024-04-16
US20110076719A1 (en) 2011-03-31
US9127264B2 (en) 2015-09-08
BRPI0821467A2 (pt) 2014-10-14
PL2240578T3 (pl) 2019-09-30
CN101910401A (zh) 2010-12-08
CN110066782A (zh) 2019-07-30
MX2010007344A (es) 2010-11-09
CA2710260A1 (en) 2009-07-16
BRPI0821467B8 (pt) 2021-05-25
BRPI0821467B1 (pt) 2019-10-15
AR069892A1 (es) 2010-02-24
EP3521422A1 (en) 2019-08-07
JP2011507550A (ja) 2011-03-10
EP2240578A1 (en) 2010-10-20
DK2240578T3 (da) 2019-06-17
EP2240578B1 (en) 2019-03-20
CA2710260C (en) 2023-07-11
JP5806465B2 (ja) 2015-11-10
KR20100114057A (ko) 2010-10-22
AU2008346817B2 (en) 2014-07-24
US20090181423A1 (en) 2009-07-16
PT2240578T (pt) 2019-06-19

Similar Documents

Publication Publication Date Title
GT201200189A (es) Antagonistas de pcsk9
JO3118B1 (ar) تراكيب وطرق لبروتين c5 المتمم يستهدف الأجسام المضادة
EA201171494A1 (ru) Миметики белка smac
EA201790309A1 (ru) Антитела к fap, способы их получения и применения
EA201170242A1 (ru) Модифицированные бычьи полипептиды g-csf и их применение
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
MX2007013759A (es) Agentes de union de esclerostina.
UY34254A (es) Proteínas y péptidos modificados.
EA200701918A1 (ru) Белок липокалин
CY1113199T1 (el) Σταθεροποιημενες συνθεσεις γλυκοσερεμπροσιδασης
EA201201435A1 (ru) ГЕТЕРОДИМЕРНЫЕ АНТИТЕЛО-Fc-СОДЕРЖАЩИЕ БЕЛКИ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
MX2014005108A (es) Constructos de polipeptidos y sus usos.
EA201000327A1 (ru) Белок
UY32501A (es) Anticuerpo antagonista específico para el heterodímero alfa4-beta7
PH12013502234A1 (en) Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
EA201390254A1 (ru) Модифицированные полипептиды релаксина и их применение
BR112015013525A2 (pt) método para produção de uma proteína de fusão, bem como composição compreendendo uma proteína de fusão
IN2012DN05169A (es)
BRPI0821467B8 (pt) composição de furina recombinante, método para produzir a composição de furina recombinante, e, método para produzir uma proteína madura utilizando a composição de furina recombinante
BRPI0819092A2 (pt) Evolução direcionada usando proteínas que compreendem aminoácidos não naturais.
ECSP13012673A (es) Métodos y composiciones para inmunoterapia para enfermedad neural
EA201291180A1 (ru) Композиции и способы применения терапевтических антител против белка, родственного рецептору липопротеинов низкой плотности 6 (lrp6)
EA201291065A1 (ru) Антитела против vla-4
PL2358756T5 (pl) Ludzkie przeciwciała o wysokim powinowactwie wobec pcsk9
EA201290541A1 (ru) Модифицированные бычьи соматотропиновые полипептиды и их применение

Legal Events

Date Code Title Description
FB Suspension of granting procedure